CDX2 and neoplasm: Data from miRNA target prediction databases and a literature search identified numerous tumor suppressive targets of the oncogenic miR-9, including FOXO1 in both non-small cell lung cancer [33] and endometrial cancer [34] and CDX2 in gastric cancer [35].